Research  /  Net Peptide Content vs. Purity
Research guide

Net Peptide Content vs. Purity: Why Labeled Milligrams Aren't All Peptide

Aminent Labs Research·Updated July 2026·10 min read·For Research Use Only

A vial labeled "5 mg" of a lyophilized research peptide almost never contains 5 mg of peptide. The white powder is a mixture: the target sequence, some closely related peptidic impurities, bound counter-ions left over from purification, adsorbed water, and traces of organic solvent. For a researcher weighing out material or reconstituting a stock to a target concentration in milligrams per milliliter, the gap between the labeled mass and the actual peptide mass is not a rounding error — it can be 15% to 40% of the powder. Two numbers on a certificate of analysis (COA) describe this, and they are routinely confused: chromatographic purity and net peptide content. They answer different questions, and you need both to know how much of your target molecule is actually in the vial.

Two questions, two different numbers

Chromatographic purity, usually reported as "% by HPLC (UV 210–220 nm)," answers a narrow question: of all the peptide-related species that eluted from the column, what fraction is the main peak? A reversed-phase HPLC run separates the target peptide from deletion sequences, truncations, oxidized or deamidated variants, and other synthesis by-products. The area of the main peak divided by the total peak area, at a wavelength where the amide backbone absorbs (210–220 nm), is the purity figure. As Bachem's analytical guide states, "the area of the main peak in relation to the total area of all peaks reflects the peptide purity."

Net peptide content (NPC), sometimes called "peptide content" or "peptide assay," answers a completely different question: what percentage of the total powder mass is peptide at all? It is the fraction of the powder that is peptidic material — the target plus its peptidic impurities — as opposed to counter-ions, water, salts, and residual solvents that carry no amide bonds. Bachem is explicit that "NPC and purity are not equivalent, because the former includes peptidic contaminants." A batch can be 98% pure by HPLC and still be only 80% peptide by mass, because purity measures composition among peptides while content measures peptide versus everything else.

The two are orthogonal. A crude peptide with poor purity but minimal salt could, in principle, have high net content; a highly purified peptide loaded with trifluoroacetate counter-ions can have excellent purity but modest net content. This is why a serious COA lists both, and why treating a "99% purity" label as if it meant "99% peptide by weight" produces stock solutions that are systematically too dilute.

What the rest of the powder is

If a lyophilized peptide is only 60–90% peptide, where does the remaining mass go? Three main places.

Add these up and the arithmetic is stark: as several testing labs describe it, a vial nominally holding 5 mg of a 99%-pure peptide might contain only 3.5–4 mg of actual peptide, with the balance being salt and moisture. Reported NPC values for synthetic peptides commonly land in the 60–90% range.

How salt form drives net content: TFA vs. acetate

The counter-ion is usually the single largest non-peptide contributor, and the choice of salt form changes the number appreciably. The reason is molecular weight. Trifluoroacetate has a formula weight near 114 g/mol; acetate is about 59 g/mol. Because a peptide binds roughly one counter-ion per positive charge, swapping TFA for acetate on a multiply-charged peptide removes a meaningful chunk of "dead weight" and raises the net peptide content of the powder, even though the peptide sequence — and its HPLC purity — is unchanged.

You can estimate the effect directly. A widely used approximation for theoretical net peptide content is:

Theoretical NPC = MWpeptide ÷ (MWpeptide + n × MWcounter-ion)

where n is the number of counter-ion binding sites (basic side chains plus a free N-terminal amine). AmbioPharm gives a clean worked example: a peptide of MW 1000 with a free N-terminus and one lysine has two TFA binding sites, so its theoretical content is 1000 ÷ (1000 + 2 × 114) = 1000 ÷ 1228 ≈ 0.81, or 81%. Repeat the same calculation with acetate (59) instead of TFA (114) and the denominator falls to 1118, giving about 89%. The identical peptide, at the identical HPLC purity, is 81% peptide by mass as the TFA salt and 89% as the acetate salt — roughly a 10-percentage-point difference driven entirely by the counter-ion.

Real measurements confirm that TFA is far from negligible. A 2025 study on TFA as a counter-ion found that, after purification and lyophilization, one model peptide retained about 0.333 mg TFA per mg of peptide salt — roughly 26% of the salt's weight was counter-ion — and that peptides can carry TFA in excess of the amount predicted by charge alone, because of strong electrostatic association. The same work quantified how much the salt form shifts the effective molecular weight: for that peptide the TFA salt (1752.6 Da) versus the chloride salt (1438.3 Da) differed by 314 Da, and the authors warn that "TFA can introduce a weighting error due to differences in the molecular weights of its salt forms." The lesson generalizes: counter-ions are not passive filler you can ignore when you put powder on a balance.

How net peptide content is actually measured

Because you cannot read net content off a UV chromatogram, it has to be measured by orthogonal methods. Three are standard.

Why this matters for accurate mg/mL in the lab

The practical payoff is in reconstitution. Suppose you want a stock at a defined molar concentration, or simply an accurate mg-of-peptide-per-mL figure for an in-vitro experiment. If you weigh 10 mg of powder and treat it as 10 mg of peptide, but the material is 80% net content at 98% purity, the peptide you actually delivered is closer to 10 × 0.80 × 0.98 = 7.8 mg. Every downstream concentration is off by more than 20%, in the same direction, every time — a systematic error that quietly shifts concentration-response curves, EC50 estimates, and anything normalized to concentration.

The correction is straightforward once you have the COA numbers. To get the moles of target peptide in a weighed portion of powder:

moles = (masspowder × NPC% × purity%) ÷ MW

For example, 100 mg of powder at 85% NPC and 98% purity with a peptide MW of 1500 g/mol contains 100 × 0.85 × 0.98 = 83.3 mg of target peptide, or about 55.5 µmol. Divide by the volume of diluent to get molarity, or divide the target-peptide mass by the volume to get an honest mg/mL. Because net content depends on salt form, two lots of the same sequence — one TFA, one acetate — can require different powder masses to hit the same true peptide concentration. That is a reproducibility issue if it goes unnoticed between lots.

A few practical habits follow from all this. Read both purity and net content off the COA, not just the headline purity. Note the stated salt form, and prefer lots where net content (or at least theoretical NPC from the salt form and sequence) is documented rather than assumed. Treat the labeled milligrams as gross powder mass, not peptide mass, and fold NPC and purity into the calculation whenever concentration accuracy matters. And handle hygroscopic powders in a way that limits fresh water uptake, since moisture added after the COA was issued erodes the net content the certificate reported.

FAQ

Is a 99% pure peptide 99% peptide by weight? No. Purity is the main-peak fraction among peptide species detected by HPLC. Net peptide content is the fraction of total powder mass that is peptide. A 99%-pure peptide can be 75–90% peptide by weight once counter-ions, water, and residual solvents are counted.

Which counter-ion gives higher net content, TFA or acetate? Acetate. Its formula weight (~59 g/mol) is about half that of trifluoroacetate (~114 g/mol), so for the same number of charged sites, the acetate salt carries less non-peptide mass and shows a higher net peptide content, even though the sequence and HPLC purity are identical.

How is net peptide content determined? Primarily by quantitative amino acid analysis (acid hydrolysis to free amino acids, then quantitation against a standard) or by elemental nitrogen analysis. Karl Fischer titration measures water separately, and counter-ion content is quantified by methods such as 19F-NMR or ion chromatography.

Why can't HPLC purity see the salt and water? UV detection at 210–220 nm responds to the amide backbone. TFA, water, and most inorganic salts have little or no absorbance there, so they do not produce peaks and are simply invisible to a purity calculation — while still contributing to the mass on the balance.

What is a typical net peptide content? Reported values for synthetic peptides commonly fall in the 60–90% range, depending on sequence, number of basic residues, salt form, and residual moisture.

References

  1. Bachem — Quality Control of Amino Acids & Peptides: A Guide (net peptide content vs. purity, counter-ions, methods).
  2. Towards a Consensus for the Analysis and Exchange of TFA as a Counterion in Synthetic Peptides. PMC (PMC12389442).
  3. AmbioPharm — How Is Theoretical Net Peptide Content Calculated? (formula and worked example).
  4. ICH Q3C (R9) Guideline for Residual Solvents (solvent classes and limits).
  5. Accurate quantitation of standard peptides used for quantitative proteomics (amino acid analysis as reference method). PMC (PMC2766299).
  6. Quantifying trifluoroacetic acid as a counterion in drug discovery by 19F NMR and capillary electrophoresis. ScienceDirect.
  7. Sigma-Aldrich (Merck) — Explanation of Peptide Content and Sample Amount Determination.
Related research
How to Read a Peptide COA Where net peptide content sits alongside purity, identity, and lot verification. HPLC Purity vs Mass Spectrometry Why chromatographic purity can't see the salt and water on the balance. Peptide Impurities Explained The peptidic by-products counted inside purity — distinct from counter-ions and water. GLP-2 TZ (Tirzepatide) — Research Overview Receptor pharmacology and characterization of a dual GIP/GLP-1 agonist studied in preclinical work. Peptide Nomenclature and Sequence Notation Counter-ion notation, terminal modifications, and monoisotopic versus average mass.
For Research Use Only. All Aminent Labs materials are intended solely for in-vitro research and laboratory use — not for human or veterinary use. See our GLP-2 TZ page, browse the catalog, or view certificates of analysis.